$7.25
-2.12-22.64%
Last update: Sep 6, 7:41 AM
15 minutes delayed
Avalo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Avalo Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $-14.07 | $-6.70 | -110.0 % |
Mar 2024 | 2024-05-13 | $-6.11 | $-1.18 | -417.8 % |
Dec 2023 | 2024-03-29 | $-10.12 | $-4.80 | -110.8 % |
Sep 2023 | 2023-11-09 | $-26.40 | $-264.00 | 90.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-03-29 | $571.00K | $300.00K | 90.3 % |
Sep 2023 | 2023-11-09 | $236.00K | $1.00M | -76.4 % |
Jun 2023 | 2023-08-03 | $643.00K | $500.00K | 28.6 % |
Mar 2023 | 2023-05-04 | $475.00K | $1.00M | -52.5 % |
Avalo Therapeutics (AVTX) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-14.07, which missed the estimate of $-6.70.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.